title: Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. III. Immunosuppressive activities of dunaimycins.
abstract: The immunosuppressive effects of the dunaimycins, a new complex of spiroketal 24-membered macrolides, were compared to cyclosporin A, ascomycin, and rapamycin. Each dunaimycin was a potent inhibitor of the mitogenic response observed in mixed murine splenocyte or human leukocyte cultures, and like immunosuppressive drugs these compounds were relatively less potent inhibitors of the constitutive proliferation of murine EL4 thymoma cells. Dunaimycin D4S showed no selectivity in inhibiting the mitogenic response of spleen cells to concanavalin A, pokeweed mitogen, lipopolysaccharide, or phytohemagglutinin. Cyclosporin A and ascomycin did not inhibit interleukin 2 dependent proliferation, whereas the dunaimycins and rapamycin blocked the uptake of [3H]thymidine in mixed cultures supplemented with exogenous interleukin 2. In addition, dunaimycin D4S had no apparent affinity for cyclosporin A or FK-506 immunophilins. Although the dunaimycins inhibited the activity of Na+, K(+)-ATPase, inhibition of this enzyme appeared insufficient to explain the biological activity of these new macrolides. Over a narrow concentration range, dunaimycin D4S showed in vivo immunosuppressive activity in the murine popliteal lymph node hyperplasia model.
authors.affiliation: Pharmaceutical Products Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064.
authors.forename: N S
authors.initials: NS
authors.lastname: Burres
authors.forename: U
authors.initials: U
authors.lastname: Premachandran
authors.forename: A
authors.initials: A
authors.lastname: Frigo
authors.forename: S J
authors.initials: SJ
authors.lastname: Swanson
authors.forename: K W
authors.initials: KW
authors.lastname: Mollison
authors.forename: T A
authors.initials: TA
authors.lastname: Fey
authors.forename: R A
authors.initials: RA
authors.lastname: Krause
authors.forename: V A
authors.initials: VA
authors.lastname: Thomas
authors.forename: B
authors.initials: B
authors.lastname: Lane
authors.forename: L N
authors.initials: LN
authors.lastname: Miller
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007959:Lymphocyte Culture Test, Mixed; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009840:Oligomycins / Q000494:pharmacology; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors; D016559:Tacrolimus / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D009840:Oligomycins; C031004:oligomycin A; D016572:Cyclosporine; D000254:Sodium-Potassium-Exchanging ATPase; D016559:Tacrolimus